Matthew M. Walsh, EVP, Chief Financial Officer at Allergan plc (AGN), bought 24,416 shares at $160.94 ($3.9M) on 2018-02-21, disclosed to the SEC on 2018-02-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.59 | 9,340 | $1.5M | 38.2% |
| 2 | $160.59 | 13,076 | $2.1M | 53.5% |
| 3 | $160.94 | 2,000 | $322K | 8.2% |
| Total | $160.62 avg | 24,416 | $3.9M | 100% |
| Filing → |
| CERT | BUY | 2020-12-16 | $115K | — | Filing → |
| AGN | BUY | 2018-11-19 | $157K | — | Filing → |
| AGN | BUY | 2018-03-08 | $154K | — | Filing → |